Cladis Investment Advisory’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.91M Sell
4,599
-670
-13% -$248K 0.89% 32
2026
Q1
$1.43M Buy
5,269
+1,311
+33% +$390K 0.78% 40
2025
Q4
$1.31M Sell
3,958
-449
-10% -$152K 0.72% 45
2025
Q3
$1.52M Buy
4,407
+2,021
+85% +$611K 0.87% 36
2025
Q2
$744K Buy
2,386
+285
+14% +$109K 0.47% 64
2025
Q1
$1.1M Hold
2,101
0.8% 40
2024
Q4
$1.06M Sell
2,101
-100
-5% -$56.8K 0.75% 44
2024
Q3
$1.29M Sell
2,201
-305
-12% -$173K 0.89% 38
2024
Q2
$1.28M Sell
2,506
-8
-0.3% -$3.92K 0.93% 30
2024
Q1
$1.24M Sell
2,514
-125
-5% -$63.5K 0.91% 37
2023
Q4
$1.39M Sell
2,639
-15
-0.6% -$8K 1.09% 27
2023
Q3
$1.34M Buy
2,654
+318
+14% +$157K 1.17% 24
2023
Q2
$1.12M Hold
2,336
0.98% 30
2023
Q1
$1.1M Hold
2,336
0.99% 29
2022
Q4
$1.24M Buy
2,336
+150
+7% +$79.5K 1.23% 23
2022
Q3
$1.1M Buy
2,186
+9
+0.4% +$4.73K 1.2% 24
2022
Q2
$1.12M Hold
2,177
1.12% 26
2022
Q1
$1.11M Hold
2,177
0.9% 33
2021
Q4
$1.09M Buy
+2,177
New +$985K 0.88% 34

Other funds holding UNH

Cladis Investment Advisory's UNH Position: Q2 2026 in Review

Cladis Investment Advisory reduced its UnitedHealth (UNH) stake by 13% in Q2 2026, selling an estimated $248K and leaving 4,599 shares worth $1.91M. The position accounts for 0.89% of the portfolio, ranked #32.

Cladis Investment Advisory first reported a position in UNH in Q4 2021 and has held it in 19 quarters since. 3,386 funds tracked by Wall St. Rank hold UNH as of Q2 2026.

  • Cladis Investment Advisory held 4,599 shares of UnitedHealth worth $1.91M as of Q2 2026.
  • Cladis Investment Advisory sold 670 UnitedHealth shares in Q2 2026, an estimated $248K.
  • UnitedHealth made up 0.89% of Cladis Investment Advisory's portfolio in Q2 2026, its #32 holding.
  • Cladis Investment Advisory first reported a position in UnitedHealth in Q4 2021 and has held it in 19 quarters since.
  • 3,386 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.

Based on Cladis Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.